SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-021496
Filing Date
2020-05-06
Accepted
2020-05-05 21:58:50
Documents
105
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 MYGN-10Q-20200331 mygn-10q_20200331.htm   iXBRL 10-Q 3781242
2 EX-10.1 mygn-ex101_182.htm EX-10.1 1200456
3 EX-31.1 mygn-ex311_8.htm EX-31.1 16755
4 EX-32.1 mygn-ex321_6.htm EX-32.1 6894
5 GRAPHIC gw44lqkdkezg000001.jpg GRAPHIC 2736
  Complete submission text file 0001564590-20-021496.txt   15998529

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mygn-20200331.xsd EX-101.SCH 70917
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mygn-20200331_cal.xml EX-101.CAL 90814
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mygn-20200331_def.xml EX-101.DEF 246879
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mygn-20200331_lab.xml EX-101.LAB 558869
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mygn-20200331_pre.xml EX-101.PRE 451999
64 EXTRACTED XBRL INSTANCE DOCUMENT mygn-10q_20200331_htm.xml XML 3639563
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Filer) CIK: 0000899923 (see all company filings)

IRS No.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 000-26642 | Film No.: 20850957
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences